| 37500305 | Predictors of mechanical ventilation and mortality in critically ill patients with COVID-19 pneumonia. | Med Intensiva (Engl Ed) | 2024 |
| 36670011 | Impact of the "Zero Resistance" program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study. | Med Intensiva (Engl Ed) | 2023 |
| 35758652 | Performance of the Cepheid Methicillin-Resistant Staphylococcus aureus/S. aureus Skin and Soft Tissue Infection PCR Assay on Respiratory Samples from Mechanically Ventilated Patients for S. aureus Screening during the Phase 2 Double-Blind SAATELLITE Study. | J Clin Microbiol | 2022 |
| 35642279 | Hourly Analysis of Mechanical Ventilation Parameters in Critically Ill Adult Covid-19 Patients: Association with Mortality. | J Intensive Care Med | 2022 |
| 33894131 | Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial. | Lancet Infect Dis | 2021 |
| 32113732 | In reply to «Big Data Analysis and Machine Learning in Intensive Care Medicine: Identifying new ethical and legal challenges». | Med Intensiva (Engl Ed) | 2020 |
| 32046864 | Bacterial resistance unrelated to antibiotic use: The perfect excuse? | Med Intensiva (Engl Ed) | 2020 |
| 33238991 | A phase Ib/IIa, randomised, double-blind, multicentre trial to assess the safety and efficacy of expanded Cx611 allogeneic adipose-derived stem cells (eASCs) for the treatment of patients with community-acquired bacterial pneumonia admitted to the intensive care unit. | BMC Pulm Med | 2020 |
| 32607967 | Baseline Characteristics and Outcomes Among Patients with Complicated Skin and Soft Tissue Infections Admitted to the Intensive Care Unit: Analysis of the Phase 3 COVERS Randomized Trial of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam. | Infect Dis Ther | 2020 |
| 30953830 | Influence of age on the clinical efficacy of tigecycline in severely ill patients. | J Glob Antimicrob Resist | 2019 |
| 30077427 | Big data and machine learning in critical care: Opportunities for collaborative research. | Med Intensiva (Engl Ed) | 2019 |
| 29023261 | Prevention of Ventilator-Associated Pneumonia: The Multimodal Approach of the Spanish ICU "Pneumonia Zero" Program. | Crit Care Med | 2018 |
| 30581828 | "The multimodal approach for ventilator-associated pneumonia prevention"-requirements for nationwide implementation. | Ann Transl Med | 2018 |
| 29616357 | Preliminary experience on the safety and tolerability of mechanical "insufflation-exsufflation" in subjects with artificial airway. | Intensive Care Med Exp | 2018 |
| 29632995 | Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study). | Intensive Care Med | 2018 |
| 29273422 | Med-Score 24: A multivariable prediction model for poststernotomy mediastinitis 24Â hours after admission to the intensive care unit. | J Thorac Cardiovasc Surg | 2018 |
| 27776936 | Compliance-guided versus FiO<sub>2</sub>-driven positive-end expiratory pressure in patients with moderate or severe acute respiratory distress syndrome according to the Berlin definition. | Med Intensiva | 2017 |
| 28785301 | Erratum to: Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). | World J Emerg Surg | 2017 |
| 27895014 | Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms. | Antimicrob Agents Chemother | 2017 |
| 27429642 | Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). | World J Emerg Surg | 2016 |
| 25448538 | Cystatin C as an early marker of acute kidney injury in septic shock. | Rev Clin Esp (Barc) | 2015 |
| 26181118 | Citrate-Based Anticoagulation for Hemofiltration Is Here to Stay, Probably! | Crit Care Med | 2015 |
| 25880421 | Combatting resistance in intensive care: the multimodal approach of the Spanish ICU "Zero Resistance" program. | Crit Care | 2015 |
| 24594437 | Guidelines for the prevention of ventilator-associated pneumonia and their implementation. The Spanish "Zero-VAP" bundle. | Med Intensiva | 2014 |
| 24829389 | Selective digestive tract decontamination and spread of colistin resistance: antibiotic prophylaxis is not a substitute for hygiene. | Antimicrob Agents Chemother | 2014 |
| 23362167 | Individualized PEEP setting in subjects with ARDS: a randomized controlled pilot study. | Respir Care | 2013 |
| 24326175 | Monitoring treatment response in abdominal sepsis with procalcitonin--if only! | Crit Care | 2013 |
| 23772047 | Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies. | J Antimicrob Chemother | 2013 |
| 23772046 | Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies. | J Antimicrob Chemother | 2013 |
| 23772045 | Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies. | J Antimicrob Chemother | 2013 |
| 23772043 | Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies. | J Antimicrob Chemother | 2013 |
| 23772042 | Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies. | J Antimicrob Chemother | 2013 |
| 23415958 | [Resistance to linezolid: a laboratory curiosity or an important clinical problem?]. | Enferm Infecc Microbiol Clin | 2013 |
| 22147112 | BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia. | Intensive Care Med | 2012 |
| 22429989 | Evaluation of chamber response function influence on IMRT verification using 2D commercial detector arrays. | Phys Med Biol | 2012 |
| 21458717 | New trends in infective endocarditis. | Enferm Infecc Microbiol Clin | 2011 |
| 21497951 | [Primary bacteremia and catheter-related bacteremia due to coagulase-negative staphylococci: is it a non-significant complication?]. | Med Intensiva | 2011 |
| 19783556 | Automated effective dose estimation in CT. | Radiat Prot Dosimetry | 2010 |
| 20530779 | Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. | JAMA | 2010 |
| 20219269 | [Debates in intensive medicine: Pro: selective decontamination]. | Med Intensiva | 2010 |
| 20206406 | [Begona Aranzadi, the first Spanish female intensivist has retired]. | Med Intensiva | 2010 |
| 20144045 | Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus. | Clin Infect Dis | 2010 |
| 19054806 | Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis. | J Intensive Care Med | 2009 |
| 19596109 | Early antibiotic treatment failure. | Int J Antimicrob Agents | 2009 |
| 19195847 | Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR). | Eur Psychiatry | 2009 |
| 18296764 | Study and evaluation of the Siemens virtual wedge factor: dosimetric monitor system and variable field effects. | Phys Med Biol | 2008 |
| 17457158 | Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. | Ann Surg | 2007 |
| 17942061 | [Consensus document (SEMES-SEMICYUC). Recommendations for the initial and multidisciplinary diagnostic management of severe sepsis in the hospital Emergency Departments]. | Med Intensiva | 2007 |
| 16192451 | A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia. | Am J Respir Crit Care Med | 2006 |
| 17067512 | [Antimycotic agent for the prevention of mycotic infections in non-neutropenic critical patients]. | Med Intensiva | 2006 |